Blackstone and TPG revive interest in buying Hologic, source says
1. Blackstone and TPG are interested in acquiring Hologic. 2. Revived interest can enhance BX's growth prospects and diversify its portfolio.
1. Blackstone and TPG are interested in acquiring Hologic. 2. Revived interest can enhance BX's growth prospects and diversify its portfolio.
Acquiring Hologic could lead to increased revenues and strengthen BX's presence in health tech, similar to its prior successful acquisitions. Historically, such multi-sector investments have led to significant returns for BX.
The acquisition aligns with BX's strategy to diversify and capture lucrative sectors like medical devices, suggesting considerable growth potential and investor interest.
The potential acquisition would likely require time for integration and realization of synergies, placing its impact over a longer timeline. Past instances show investment in health tech has yielded extended growth opportunities.